IP Library Granted Patent US 9,410,197
Granted Patent B2
US 9,410,197 · App. 14/542,980 · Granted Aug 9, 2016

Compound for sequencing by synthesis

Inventors: Frank Bergmann (Iffeldorf, DE); Dieter Heindl (Paehl, DE); Jessica Steger-Domandl (Munich, DE)
Assignee: ROCHE MOLECULAR SYSTEMS INC.
C12Q1/6869C07H19/10C07H19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,197
App. No.
14/542,980
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention provides deoxynucleoside tri- or tetraphosphate comprising a 3′ nitrate and a detectable label covalently bound to the oxygen atom of an oxymethyl or oxyallyl or oxypropargyl substitution of a nucleobase. Such compounds provide new possibilities for future Sequencing by Synthesis technologies.

Claims (9)

1. A method for analyzing a DNA sequence comprising the steps of

a) providing a nucleic acid template with a primer hybridized to said template forming a primer/template hybridization complex,

b) adding DNA polymerase, and at least one labeled deoxynucleoside tri- or tetraphosphate comprising a 3′-nitrate and a detectable label covalently bound to the oxygen atom of an oxymethyl or oxyallyl or oxypropargyl substitution of a nucleobase, and a pyrophosphatase,

c) subjecting said reaction mixture to conditions which enable a DNA polymerase catalyzed primer extension reaction,

d) determining, whether said compound has been incorporated into said primer/template hybridization complex,

e) simultaneously removing the 3′-nitrate group and optionally said label from said complex by means of adding a sulfide or a mercaptane, and

f) repeating steps b) to e) at least once.

2. The method according to claim 1 , wherein a different labeled deoxynucleoside tri- or tetraphosphate compound is added during repeat of step b).

3. The method according to claim 1 , wherein a mixture of 4 differently labeled deoxynucleoside tri- or tetraphosphate compounds representing A, G, C and T/U are used in step b).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2014
From: BERGMANN, FRANK; HEINDL, DIETER; STEGER-DOMANDL, JESSICA
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 034187/0185 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2014
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 034187/0225 →
Priority Claims (1)
EP 13193588 · Nov 20, 2013 · regional
Continuity (1)
Related Publication 20150140561A1 · May 21, 2015